US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4

Frank James Ward (Inventor), Robert Norman Barker (Inventor), Lekh Nath Dahal (Inventor)

Research output: Patent

Abstract

The invention provides materials and methods relating to antibodies specific for the soluble form of CTLA-4 (sCT-LA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
Original languageEnglish
IPCUS20120107320
Publication statusPublished - 28 Feb 2009

Fingerprint

HLA-D Antigens
Antibodies

Keywords

  • antibody
  • costimulation
  • CTLA4

Cite this

Ward, F. J., Barker, R. N., & Dahal, L. N. (2009). IPC No. US20120107320. US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4.

US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4. / Ward, Frank James (Inventor); Barker, Robert Norman (Inventor); Dahal, Lekh Nath (Inventor).

IPC No.: US20120107320.

Research output: Patent

Ward FJ, Barker RN, Dahal LN, inventors. US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4. US20120107320. 2009 Feb 28.
Ward, Frank James (Inventor) ; Barker, Robert Norman (Inventor) ; Dahal, Lekh Nath (Inventor). / US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4. IPC No.: US20120107320.
@misc{a1aef09a61194f9b8ac91ce41cfb6c83,
title = "US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4",
abstract = "The invention provides materials and methods relating to antibodies specific for the soluble form of CTLA-4 (sCT-LA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.",
keywords = "antibody, costimulation, CTLA4",
author = "Ward, {Frank James} and Barker, {Robert Norman} and Dahal, {Lekh Nath}",
year = "2009",
month = "2",
day = "28",
language = "English",
type = "Patent",
note = "US20120107320",

}

TY - PAT

T1 - US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4

AU - Ward, Frank James

AU - Barker, Robert Norman

AU - Dahal, Lekh Nath

PY - 2009/2/28

Y1 - 2009/2/28

N2 - The invention provides materials and methods relating to antibodies specific for the soluble form of CTLA-4 (sCT-LA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.

AB - The invention provides materials and methods relating to antibodies specific for the soluble form of CTLA-4 (sCT-LA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.

KW - antibody

KW - costimulation

KW - CTLA4

M3 - Patent

ER -